title: Randomisation is essential in Ebola drug trials.
authors.affiliation: Institute for Biomedical Ethics, University of Basel, 4056 Basel, Switzerland. Electronic address: david.shaw@unibas.ch.
authors.forename: David
authors.initials: D
authors.lastname: Shaw
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000941:ethics*
chemical_list: D000998:Antiviral Agents